Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0000950142-25-001097 0001907225 XXXXXXXX LIVE 23 Class A common stock, $0.01 par value per share 04/30/2026 false 0001595527 649439304 American Strategic Investment Co. 222 Bellevue Avenue Newport RI 02840 Michael R. Anderson 212-415-6500 Bellevue Capital Partners, LLC 222 Bellevue Avenue Newport RI 02840 0001907225 N Bellevue Capital Partners, LLC b WC N DE 0.00 1823384.00 0.00 1823384.00 1823384.00 N 67.7 OO Y AR Global Investments, LLC b OO N DE 0.00 752764.00 0.00 752764.00 752764.00 N 28.0 OO Y American Realty Capital III, LLC b OO N DE 0.00 752764.00 0.00 752764.00 752764.00 N 28.0 OO Y New York City Special Limited Partnership, LLC b OO N DE 0.00 752764.00 0.00 752764.00 752764.00 N 28.0 OO Y New York City Advisors, LLC b OO N DE 0.00 752764.00 0.00 752764.00 752764.00 N 28.0 OO Y Nicholas S. Schorsch b OO N X1 0.00 1849943.00 0.00 1849943.00 1849943.00 N 68.7 IN Y Edward M. Weil, Jr. b OO N X1 109.00 0.00 109.00 0.00 109.00 N 0.0 IN Class A common stock, $0.01 par value per share American Strategic Investment Co. 222 Bellevue Avenue Newport RI 02840 This Amendment No. 23 (the "Amendment") to Schedule 13D amends and supplements the Schedule 13D originally filed with the United States Securities and Exchange Commission (the "SEC") on February 11, 2022 relating to the shares of Class A common stock, par value $0.01 per share (the "Class A Common Stock"), of American Strategic Investment Co. (f/k/a New York City REIT, Inc.), a Maryland corporation (the "Issuer"), as subsequently amended (the "Schedule 13D"). This Amendment updates the Schedule 13D to reflect certain recent transactions as reported under Item 5 below. Unless indicated otherwise, all items left blank remain unchanged and any items which are reported are deemed to amend and supplement the existing items in the Schedule 13D. Capitalized terms used herein without definition shall have the meaning set forth in the Original Schedule 13D. Item 5 of the Schedule 13D is amended and supplemented by incorporating by reference the information set forth in boxes (11) and (13) of the cover pages to this Amendment for each of the Reporting Persons, and such information is incorporated herein by reference. The percentages reported herein are calculated based upon 2,692,941 outstanding shares of Class A Common Stock as of April 14, 2026 as reported by the Issuer in its Annual Report on Form 10-K filed with the SEC on April 15, 2026. See Item 5(a). On April 30, 2026, 232,098 fully-vested shares of Class A common stock of the Issuer were issued pursuant to the 2020 Advisor Omnibus Incentive Compensation Plan of the Issuer to, and in connection with fees earned by, New York City Advisors, LLC, the external advisor of the Issuer. See Item 5(a). See Item 5(a). Bellevue Capital Partners, LLC /s/ Matthew A. Lyons Attorney-in-Fact 05/04/2026 AR Global Investments, LLC /s/ Matthew A. Lyons Attorney-in-Fact 05/04/2026 American Realty Capital III, LLC /s/ Matthew A. Lyons Attorney-in-Fact 05/04/2026 New York City Special Limited Partnership, LLC /s/ Matthew A. Lyons Attorney-in-Fact 05/04/2026 New York City Advisors, LLC /s/ Matthew A. Lyons Attorney-in-Fact 05/04/2026 Nicholas S. Schorsch /s/ Matthew A. Lyons Attorney-in-Fact 05/04/2026 Edward M. Weil, Jr. /s/ Matthew A. Lyons Attorney-in-Fact 05/04/2026